184 related articles for article (PubMed ID: 22495425)
1. Methadone and metabolites in hair of methadone-assisted pregnant women and their infants.
Himes SK; Goodwin RS; Rock CM; Jones HE; Johnson RE; Wilkins DG; Huestis MA
Ther Drug Monit; 2012 Jun; 34(3):337-44. PubMed ID: 22495425
[TBL] [Abstract][Full Text] [Related]
2. Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes.
de Castro A; Jones HE; Johnson RE; Gray TR; Shakleya DM; Huestis MA
Ther Drug Monit; 2011 Aug; 33(4):443-52. PubMed ID: 21743375
[TBL] [Abstract][Full Text] [Related]
3. Maternal methadone dose, placental methadone concentrations, and neonatal outcomes.
de Castro A; Jones HE; Johnson RE; Gray TR; Shakleya DM; Huestis MA
Clin Chem; 2011 Mar; 57(3):449-58. PubMed ID: 21245372
[TBL] [Abstract][Full Text] [Related]
4. Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.
Gray TR; Choo RE; Concheiro M; Williams E; Elko A; Jansson LM; Jones HE; Huestis MA
Addiction; 2010 Dec; 105(12):2151-9. PubMed ID: 20854338
[TBL] [Abstract][Full Text] [Related]
5. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication.
Kaltenbach K; Holbrook AM; Coyle MG; Heil SH; Salisbury AL; Stine SM; Martin PR; Jones HE
Addiction; 2012 Nov; 107 Suppl 1(0 1):45-52. PubMed ID: 23106926
[TBL] [Abstract][Full Text] [Related]
6. Stereoselective Analysis of Methadone and EDDP in Laboring Women and Neonates in Plasma and Dried Blood Spots and Association with Neonatal Abstinence Syndrome.
Metzger IF; Thomas AE; Evrard CA; Jones DR; Masters AR; Haas DM; Haneline LS; Quinney SK
Am J Perinatol; 2021 Jul; 38(9):968-975. PubMed ID: 32052397
[TBL] [Abstract][Full Text] [Related]
7. Transplacental methadone exposure and risk of Neonatal Opioid Withdrawal Syndrome.
Bhatt-Mehta V; Jing X; Wang X; Zhu HJ
Pharmacotherapy; 2024 Jan; 44(1):22-27. PubMed ID: 37574548
[TBL] [Abstract][Full Text] [Related]
8. Maternal vagal tone change in response to methadone is associated with neonatal abstinence syndrome severity in exposed neonates.
Jansson LM; Dipietro JA; Elko A; Velez M
J Matern Fetal Neonatal Med; 2007 Sep; 20(9):677-85. PubMed ID: 17701668
[TBL] [Abstract][Full Text] [Related]
9. The relationship between maternal methadone dose at delivery and neonatal outcome: methodological and design considerations.
Jones HE; Jansson LM; O'Grady KE; Kaltenbach K
Neurotoxicol Teratol; 2013; 39():110-5. PubMed ID: 24099621
[TBL] [Abstract][Full Text] [Related]
10. Maternal Substance Use and Neonatal Abstinence Syndrome: A Descriptive Study.
McQueen KA; Murphy-Oikonen J; Desaulniers L
Matern Child Health J; 2015 Aug; 19(8):1756-65. PubMed ID: 25656717
[TBL] [Abstract][Full Text] [Related]
11. Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison.
Unger A; Jagsch R; Jones H; Arria A; Leitich H; Rohrmeister K; Aschauer C; Winklbaur B; Bäwert A; Fischer G
Addiction; 2011 Jul; 106(7):1355-62. PubMed ID: 21438938
[TBL] [Abstract][Full Text] [Related]
12. Variations in Infant CYP2B6 Genotype Associated with the Need for Pharmacological Treatment for Neonatal Abstinence Syndrome in Infants of Methadone-Maintained Opioid-Dependent Mothers.
Mactier H; McLaughlin P; Gillis C; Osselton MD
Am J Perinatol; 2017 Jul; 34(9):918-921. PubMed ID: 28320034
[No Abstract] [Full Text] [Related]
13. Buprenorphine compared with methadone in opioid-dependent pregnant women: How does it affect neonatal abstinence syndrome?
Bivin B; Waring A; Alves P
J Am Assoc Nurse Pract; 2019 Dec; 33(2):119-125. PubMed ID: 31809398
[TBL] [Abstract][Full Text] [Related]
14. Neonatal neurobehavior effects following buprenorphine versus methadone exposure.
Coyle MG; Salisbury AL; Lester BM; Jones HE; Lin H; Graf-Rohrmeister K; Fischer G
Addiction; 2012 Nov; 107 Suppl 1(0 1):63-73. PubMed ID: 23106928
[TBL] [Abstract][Full Text] [Related]
15. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
Kelty E; Hulse G
Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981
[TBL] [Abstract][Full Text] [Related]
16. Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women.
Metz V; Jagsch R; Ebner N; Würzl J; Pribasnig A; Aschauer C; Fischer G
Hum Psychopharmacol; 2011 Aug; 26(6):412-21. PubMed ID: 21823171
[TBL] [Abstract][Full Text] [Related]
17. Methadone and perinatal outcomes: a prospective cohort study.
Cleary BJ; Eogan M; O'Connell MP; Fahey T; Gallagher PJ; Clarke T; White MJ; McDermott C; O'Sullivan A; Carmody D; Gleeson J; Murphy DJ
Addiction; 2012 Aug; 107(8):1482-92. PubMed ID: 22340442
[TBL] [Abstract][Full Text] [Related]
18. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
[TBL] [Abstract][Full Text] [Related]
19. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
[TBL] [Abstract][Full Text] [Related]
20. Neonatal abstinence syndrome after methadone or buprenorphine exposure.
Jones HE; Kaltenbach K; Heil SH; Stine SM; Coyle MG; Arria AM; O'Grady KE; Selby P; Martin PR; Fischer G
N Engl J Med; 2010 Dec; 363(24):2320-31. PubMed ID: 21142534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
